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Abstract The Mammalian Phenotype Ontology (MP) is a
structured vocabulary for describing mammalian pheno-
types and serves as a critical tool for efficient annotation
and comprehensive retrieval of phenotype data. Impor-
tantly, the ontology contains broad and specific terms,
facilitating annotation of data from initial observations or
screens and detailed data from subsequent experimental
research. Using the ontology structure, data are retrieved
inclusively, i.e., data annotated to chosen terms and to
terms subordinate in the hierarchy. Thus, searching for
‘‘abnormal craniofacial morphology’’ also returns annota-
tions to ‘‘megacephaly’’ and ‘‘microcephaly,’’ more spe-
cific terms in the hierarchy path. The development and
refinement of the MP is ongoing, with new terms and
modifications to its organization undergoing continuous
assessment as users and expert reviewers propose expan-
sions and revisions. A wealth of phenotype data on mouse
mutations and variants annotated to the MP already exists
in the Mouse Genome Informatics database. These data,
along with data curated to the MP by many mouse muta-
genesis programs and mouse repositories, provide a plat-
form for comparative analyses and correlative discoveries.
The MP provides a standard underpinning to mouse phe-
notype descriptions for existing and future experimental
and large-scale phenotyping projects. In this review we
describe the MP as it presently exists, its application to
phenotype annotations, the relationship of the MP to other
ontologies, and the integration of the MP within large-scale
phenotyping projects. Finally we discuss future application
of the MP in providing standard descriptors of the
phenotype pipeline test results from the International
Mouse Phenotype Consortium projects.
Introduction
Systematic collection and curation of phenotypic descrip-
tions began in the 1940s as textual synopses for mouse
mutants (Snell 1941). Then, maintaining and updating text
manually was easy (very few mutants known) and there
were no electronic records requiring search mechanisms or
computer-parsable formats. Now there are over 24,300
mutant alleles that have been identified in mice1 with
established phenotypes, representing mutant alleles in over
9,600 genes (Table 1). Also, there are nearly 4,700 QTL
(quantitative trait loci) that represent genomic regions
associated with particular phenotypic traits. Phenotypic
characterization data continue to expand rapidly. The Mouse
Genome Informatics (MGI http://www.informatics.jax.org)
(Blake et al. 2011; Eppig et al. 2012) database, the primary
international database for mouse, adds several hundred new
mutant alleles with reported phenotypes to the database each
month.
Researchers increasingly develop sophisticated new
mouse models of human disease and analyze phenotypes in
mice carrying complex engineered and mutant allele
combinations on multiple genetic backgrounds. The unit of
annotation for a phenotype, therefore, must be the ani-
mal(s) or ‘‘whole’’ genotype assessed, annotated to MP
terms and accompanied by key conditional variables (e.g.,
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treatment, age of onset). Thus, the actual number of phe-
notype-bearing populations far exceeds the number of
mutant alleles. Such data maintained by continuous
resynthesis of information as descriptive text are (1)
impractical to maintain; (2) unreliable to search without
structured format and controlled vocabularies, producing
false-negative and false-positive search errors; and (3) not
amenable to computational analyses.
Large-scale projects to produce a complete set of
mutations ‘‘for every gene’’ in the mouse are underway
using phenotype-driven mutagenesis approaches [cf. ENU
(N-ethyl-N-nitrosourea)] (Acevedo-Arozena et al. 2008;
Clark et al. 2004; Cook et al. 2006; Goldowitz et al. 2004)
and gene-driven approaches (cf. gene-trap and gene-
knockout programs) (Araki et al. 2009; Austin et al. 2004;
Auwerx et al. 2004; Nord et al. 2006). These new data sets
and the need to restructure phenotype data representation in
MGI prompted transformation of text-based phenotypic
descriptions into structured annotations based on the MP,
which was initiated concurrently as a phenotype annotation
tool in 2001.
Restructuring of MGI’s phenotype data included
(a) development of a data model for phenotypes in the MGI
relational database; (b) development of the MP ontology
(Smith and Eppig 2009; Smith et al. 2004) as the corner-
stone for phenotype annotation; (c) application of the MP
ontology to ongoing curation of phenotypes in MGI and the
retirement of text-based descriptions; (d) development of
new, robust access to phenotypes via redesigned web
interfaces, tracks on the MGI Mouse Genome Browser
(http://gbrowse.informatics.jax.org/cgi-bin/gbrowse/
mouse_current), and contribution of data to other genome
browser resources such as University of California Santa
Cruz (UCSC, http://genome.ucsc.edu), Ensembl (http://
www.ensembl.org) and NCBI (National Center for Bio-
technology Information, http://www.ncbi.nlm.nih.gov);
and (e) development of a human disease view of mouse
phenotypes utilizing MGI’s annotations to OMIM (Online
Mendelian Inheritance in Man, http://www.omim.org)
disease terms.
The significance of the mouse as a model organism, the
availability of its fully sequenced genome, and the accessi-
bility of mouse tissues for experimentation at all life-stages
invite new applications and exquisite experimental manip-
ulation to address key scientific questions. Integration of
experimental data using standard data descriptions and
nomenclatures is of paramount importance in maximizing
the value of the mouse model system. MGI has loaded large-
scale data from ENU phenotyping centers and laboratories
and is poised to load new phenotyping data from the
developing International Mouse Phenotyping Consortium
(IMPC, www.mousephenotype.org), allowing integration of
these data with data derived from individual laboratories and
the biomedical literature. A common interface to phenotypes
in MGI exists that allows critical phenotype and genotype
comparisons. Further, alignment of mouse mutant pheno-
types with human disease symptoms will aid in identifying
mouse genetic models with phenotypic matches as well as
the currently captured experimentally demonstrated mouse
models for human disease.
The Mammalian Phenotype Ontology (MP)
The MP is the workhorse for standardizing phenotypic
descriptions in mouse, rat, and other mammals. The MP is
a ‘‘precomposed’’ ontology, structured as a DAG (directed
acyclic graph) and using phenotype terms recognized by
research biologists and clinicians that include simple
compound concepts (e.g., liver hyperplasia, MP:0005141)
and aggregate concepts (e.g., glomerular crescent,
MP:0011506) (Fig. 1).
The MP is a flexible, expandable tool that can grow to
accommodate the anticipated rapid increase in phenotyping
data, can be applied to maximize precision and breadth of
user phenotype searches, and can facilitate an efficient
curation stream of incoming phenotype data. By annotating
phenotypes from these data sets using MP, the standardi-
zation and concurrent retrieval of terms is achieved. This
stands in contrast to natural language text, where there is
Table 1 Mutant allele and phenotype data in the Mouse Genome
Informatics database, MGIa,b,c
Data type Count
Total mutant alleles (in ES cell lines and mice) 738,364
Mutant alleles in mice 24,339
Genes with mutant alleles 14,743
Genes with mutant alleles in mice 9,636
Mammalian phenotype ontology (MP) terms 8,744
Genes with phenotype annotations 8,903
Genotypes with phenotype annotations 43,335
Total MP annotations to genotypes 227,169
Human diseases with one or more genotypic mouse models 1,148
Mouse genotypes modeling human diseases 3,668
Quantitative trait loci (QTL) 4,696
Total recombinase (Cre)-expressing transgenes and alleles 1,739
a Data as of May 5, 2012, www.informatics.jax.org. New data are
added to the MGI database daily; thus, actual counts will be higher
than those shown here
b Mutant allele counts include spontaneous, induced (e.g., by ENU),
and genetically engineered alleles. Transgenes, which are not part of
the normal mouse genome, are not included
c Mutants present only in ES cell lines versus those created in mice or
made into mice from ES cells are distinguished in several table
counts. All phenotype-related data refer to mutations present in mice
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no restriction on the variation of term names, descriptors,
or grammar, confounding data integration and limiting
effectiveness of data searches.
As of May 2012, the MP contains 8,744 terms
describing morphological, physiological, and behavior
anomalies. The top nodes are organized into 27 categories
representing biological systems, mortality terms, and
behavior, with abnormal morphological and physiological
system terms at the next node level. Phenotype data can be
annotated at any point along the structure, depending on
the detail available from information sources. Each term is
distinct and defined, aiding both curators and users in
selecting the appropriate term for their needs. In addition,
attributes and relationships among the terms are described
in the form of a DAG (Fig. 1). This allows more flexibility
than that of a simple tree, since each term can have mul-
tiple relationships to broader parent terms and more
specific child terms. The more specific terms are subsumed
by parent terms as one moves up the graph, which allows
for more complete grouping, searching, and analysis of
annotated data.
Multiple resources provide browser formats for viewing the
MP, including the Ontology Lookup Service (OLS, http://
www.ebi.ac.uk/ontology-lookup/ontologyList.do), Bioportal
(http://bioportal.bioontology.org/ontologies), and MGI’s MP
browser (http://www.informatics.jax.org/searches/MP_form.
shtml). Figure 1 shows a sample page from MGI’s MP
Browser for the phenotype term ventricular septal defect
(MP:0010402). Each term in the MP has a unique term name,
unique accession ID, synonyms, and a definition. In MGI’s MP
Browser, the relationship between parent and child terms is
visualized by indentation of each successive level of the hier-
archy. Where a term has multiple parents, each path from the
upper-level term to the term of interest displays as a separate
Fig. 1 The Mammalian Phenotype Ontology (MP) browser at MGI,
showing details for the term ‘‘ventricular septal defect’’ (MP:0010402).
Left MGI’s MP browser display shows the term name, common
synonyms and acronyms, the primary MP ID, alternate IDs, and the term
definition. The two term paths are shown as a hierarchial tree, with paths
listed in multiple sequential graphs. Each term in the MP browser is
followed by a link to MGI genotypes associated with that term or any
children of that term. Right A graphical representation of the DAG
structure for the term ‘‘ventricular septal defect.’’ The two alternate paths
from the node ‘‘cardiovascular system phenotype’’ are shown
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hierarchy, thus effectively flattening the DAG structure for web
viewing. The MP file in OBO format is available for down-
load from the MGI ftp site (ftp://ftp.informatics.jax.org/pub/
reports/index.html#pheno); it is also available in OBO and
OWL formats from the Open Biomedical Ontologies (OBO,
http://www.obofoundry.org) foundry site, OLS, and Bioportal.
The MP is a dynamic ontology, actively used and
developed by those annotating phenotypes in mouse and
other species. Requests for new terms, term revisions, and
suggestions for structural organization modifications to the
MP are frequently proposed by curators and user groups.
Suggestions for improvement and additions from the
community are submitted through the Open Biomedical
Ontologies Mammalian Phenotype Requests tracker system
at SourceForge (https://sourceforge.net/tracker/?atid=110
9502&group_id=76834) or by email to pheno@jax.org.
Expansion of the MP ontology and review of its hier-
archical structure occurs in collaboration with new phe-
notype annotation projects when the need for additional
granularity of terms is anticipated. In addition, collabora-
tive review of particular systems by expert editors together
with subject area specialists helps create terms and struc-
tures that are intuitive and useful to those communities.
Recent additions and revisions include the respiratory
system, renal/urinary system, and cardiovascular system
(with significant structural reorganization) that expanded
the MP by 714 terms. To accommodate data being gener-
ated by large-scale phenotyping efforts at the Wellcome
Trust Sanger Institute (hereafter, Sanger Institute) Mouse
Genetics Program (http://www.sanger.ac.uk/mouseportal)
and from the EUMORPHIA (Brown et al. 2005; Mandillo
et al. 2008) and EUMODIC (Beck et al. 2009; Morgan
et al. 2010) European large-scale phenotyping efforts, MP
added 38 new population-level lethality terms. These
lethality terms also will support data forthcoming from the
IMPC projects. Furthermore, 196 new MP homeostasis
terms now describe the results of phenotype pipeline tests
generated by these centers. When new MP terms are added
or revised from these annotation projects or from user
requests, relevant existing phenotype annotations at MGI
are triggered for review and revised to reflect the new
terminology as appropriate.
Along with cardiovascular system term revisions, Fyler
codes (Keane et al. 2006), a systematic, hierarchical clas-
sification of congenital heart disease (see example in
Fig. 1), were included as secondary IDs to the primary MP
ID. Fyler codes align the MP to current standards of the
cardiac disease research community and its representation
in the research and clinical literature. These codes are
consistent with the International Pediatric and Congenital
Cardiac Codes (IPCCC, http://www.ipccc.net) and enable
users to search for congenital heart defects using these
codes, IDs, or term names, with comprehensive retrieval of
information.
Applying the MP to phenotype annotations
A number of resources use the MP to describe abnormal
phenotypes (see Table 2), including MGI, the Rat Genome
Database (RGD, http://rgd.mcw.edu), Online Mendelian
Inheritance in Animals (OMIA, http://omia.angis.org.au/
home), the Sanger Institute Mouse Genetics Program,
MRC Harwell’s MouseBook (http://www.mousebook.org),
Europhenome (http://www.europhenome.org), and the
IMPC, among others. In addition, the MP is used by mouse
repositories to annotate phenotype data (or reflect down-
loaded MGI phenotype data) for describing available
mouse strains and stocks. These include the Jackson Lab-
oratory Repository (JAX Mice, http://jaxmice.jax.org),
the European Mouse Mutant Archive (EMMA, http://www.
emmanet.org), and the Mutant Mouse Regional Resource
Centers (MMRRC, http://www.mmrrc.org), among others.
MGI contains information on published spontaneous,
induced, and genetically engineered mouse mutations
(Table 1), as well as contributed or downloaded data from
large-scale mouse mutagenesis projects, including ENU, gene
trap, and knockout mutagenesis projects (see Table 3 for a list
of mutagenesis projects with data integrated into MGI). All of
these data are integrated with all of the other genomic,
expression, function, tumor and pathway data in MGI to
facilitate knowledge discovery and hypothesis building. The
MGI website presents a mutant allele in all of its studied con-
texts, which is key for discerning multigenic disease models,
genetic background effects, and allelic interactions. Tools also
are available at MGI for users who wish to separate genotypes
carrying single-gene mutations from more complex genotypes
such as conditional genotypes or those carrying transgenes,
mutations in multiple genes, or large genomic rearrangements.
Figure 2 shows an example of MP annotations to geno-
types involving the Fgfr2tm1Schl mutant allele (a mutation in
the fibroblast growth factor receptor 2 gene, the first targeted
mutation of this gene from the laboratory of Joseph
Schlessinger). Phenotype data are viewed in a matrix sum-
mary format to facilitate comparison of multiple genotypes
and genetic backgrounds or by genotype. Clicking the links
in these sections leads to an expanded view, including terms
and additional details organized by physiological system, as
well as mouse disease model data and images.
Phenotype data associated with specific terms are
retrieved in a variety of ways. A MP term or ID entered in the
Quick Search box on any MGI page will retrieve a list of
genes, alleles, and vocabulary terms. MP terms entered in the
Phenotype/Human Disease section of the advanced Genes
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Chemical Entities of Biological Interest (ChEBI) http://www.ebi.ac.uk/chebi
Collaborative Cross (CC) http://csbio.unc.edu/CCstatus
Disease Ontology (DO) http://disease-ontology.org
Diversity Outcross (DO) http://cgd.jax.org/datasets/phenotype/SvensonDO.shtml
Drosophila Genome Database (FlyBase) http://flybase.org
Ensembl http://www.ensembl.org
*European Mouse Mutant Archive (EMMA) http://www.emmanet.org
*Europhenome http://www.europhenome.org
Foundational Model of Anatomy (FMA) http://sig.biostr.washington.edu/projects/fm/AboutFM.html
Gene Ontology (GO) http://www.geneontology.org
*Gene Weaver http://www.GeneWeaver.org
Getting an Understanding of LOgical definitions (GULO) http://compbio.charite.de/svn/hpo/trunk/src/tools/gulo
Human Phenotype Ontology (HP) http://www.human-phenotype-ontology.org
International Classification of Diseases (ICD) http://www.cdc.gov/nchs/icd.htm
International Knockout Mouse Consortium (IKMC) http://www.knockoutmouse.org
*International Mouse Phenotyping Consortium (IMPC) http://www.mousephenotype.org
International Pediatric and Congenital Cardiac Code (IPCCC) http://www.ipccc.net
*Jackson Laboratory Mouse Repository (JAX Mice) http://jaxmice.jax.org
KEGG Pathways Database http://www.genome.jp/kegg/pathway.html
*Mammalian Phenotype Enrichment Analysis (MamPhEA) http://evol.nhri.org.tw/phenome/index.jsp?platform=mmus
*Mammalian Phenotype Ontology (MP) browser http://www.informatics.jax.org/searches/MP_form.shtml
*Mammalian Phenotype Ontology download from MGI site ftp://ftp.informatics.jax.org/pub/reports/index.html#pheno
Mammalian Phenotype Requests Tracker https://sourceforge.net/tracker/?atid=1109502&group_id=76834
MEDIC disease vocabulary http://ctdbase.org/voc.go?type=disease
Medical Subject Headings (MeSH) http://www.nlm.nih.gov/mesh/MBrowser.html
*MGI Mouse Genome Browser (Mouse GBrowse) http://gbrowse.informatics.jax.org/cgi-bin/gbrowse/mouse_current
*MouseFinder http://www.mousemodels.org
*MRC Harwell MouseBook http://www.mousebook.org
*Mutant Mouse Regional Resource Centers (MMRRC) http://www.mmrrc.org
National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov
*Online Mendelian Inheritance in Animals (OMIA) http://omia.angis.org.au/home
Online Mendelian Inheritance in Man (OMIM) http://www.omim.org
Ontology Lookup Service (OLS) http://www.ebi.ac.uk/ontology-lookup/ontologyList.do





Phenotype and Trait Ontology (PATO) http://code.google.com/p/pato
*Rat Genome Database (RGD) http://rgd.mcw.edu
Reactome http://www.reactome.org
*Sanger Institute Mouse Resources Portal http://www.sanger.ac.uk/mouseportal
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED-CT) http://www.ihtsdo.org/snomed-ct
*ToppGene: Candidate gene prioritization http://toppgene.cchmc.org/prioritization.jsp
Uberon, cross-species anatomy ontology http://obofoundry.org/wiki/index.php/UBERON:Main_Page
*UCSC genome browser http://genome.ucsc.edu
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and Markers Query Form or Phenotypes Query Form return
genes or alleles associated with genotypes annotated to that
term. Selecting terms in the MP Browser displays links at the
term level to genotypes annotated to that term or any child of
that term. For example, a search in MGI using either the
identifier ‘‘MP:0010402’’ or the term name ‘‘ventricular
septal defect’’ returns a list of 300 genotypes with 337
annotations representing 311 matching alleles in 232 genes,
transgenes, and markers (Fig. 3). These results include
annotations to terms listed below ‘‘ventricular septal defect’’
in the hierarchy such as ‘‘inlet ventricular septal defect’’ and
‘‘perimembraneous ventricular septal defect.’’ Thus, use of
an ontology allows the retrieval of all information associated
with a term and its children.
Phenotype data also are retrieved from the MGI Batch
Query Form and the MGI BioMart. MGI also maintains a
suite of public reports containing phenotype data for down-
load. Using MGI’s public reports and web services, MGI data
can be exported to a variety of other data providers such as
NCBI, EBI, UCSC, OMIM, and mouse mutant repositories,
where they are incorporated to enrich those resources.
Relationship of the Mammalian Phenotype Ontology
to other ontologies for model organism phenotypes
and human disease data
Comparing phenotypes among organisms as well as against
human phenotypes (and thereby with human disease) makes
it possible to discover commonalities of gene function,
pathways, and mechanisms. Because all organisms currently
have significant gaps in the experimental knowledge of
mutations and phenotypes for all genes and in the under-
standing of the function and interactions for each gene,
comparative analyses can provide clues and direction for
new experimental validation and research avenues.
At present, there is no universal phenotype ontology for all
species that could easily facilitate comparative phenotyping.
For mammals, the MP is widely accepted and applied (see
above and Table 2). For human, the Human Phenotype
Ontology (HP, http://www.human-phenotype-ontology.org)
(Robinson et al. 2008), also a precomposed ontology, is
actively being developed. For other model organisms,
approaches vary, from species-specific vocabulary lists (e.g.,
in FlyBase, the Drosophila model organism database,
http://flybase.org) to the ‘‘EQ’’ (entity ? quality) approach
(e.g., in ZFIN, the Zebrafish Information Network). In the EQ
approach, terms are composed de novo at the time of
annotation using an ‘‘entity’’ term found in other existing
ontologies [e.g., Gene Ontology (GO, http://www.geneontology.
org), Chemical Entities of Biological Interest (ChEBI,
http://www.ebi.ac.uk/chebi)] plus a ‘‘quality’’ from the Phe-
notype and Trait Ontology (PATO, http://code.google.com/
p/pato) (Gkoutos et al. 2005) that provides the term modifier
(e.g., pale, enlarged, absent). For example, ZFIN combines
the anatomy term ‘‘pericardium’’ (ZFA:0000054) with the
PATO term ‘‘edematous’’ (PATO:0001450) to create a
complete phenotype (EQ) statement ‘‘pericardium edematous,
abnormal ’’ (http://zfin.org/action/phenotype/phenotype-
statement?id=53698). The MP Ontology contains a single
precomposed term ‘‘pericardial edema’’ (MP:0001787).
Mappings between terms of phenotype ontologies har-
monize these different approaches. For the MP, direct
mappings to other precomposed phenotype ontologies such
as the HP, or indirect mappings of MP terms to EQ state-
ments (Mungall et al. 2010) are used. The EQ mapping
consists of developing a ‘‘logical definition’’ in ontological
parlance. Logical definitions for MP and HP can be com-
bined with annotations from other species databases that
use EQ statements to describe phenotypes, making multi-
species phenotype data integration and comparisons pos-
sible (Mungall et al. 2010; Washington et al. 2009).
Importantly, logical definitions enhance the MP by estab-
lishing relationships of terms to a wider suite of interop-
erating ontologies. However, aggregate terms such as
hydrocephaly or glomerular crescent require representation
as multiple EQ statements, diminishing the meaning and
recognition of these scientific/clinical terminologies.
Ontologies developed as annotation tools (e.g., MP, HP,
and GO) are improved by mapping concepts to a common
reference framework based on existing standard ontologies
(such as the global anatomy ontology Uberon, http://
obofoundry.org/wiki/index.php/UBERON:Main_Page) (Mungall
et al. 2012). Maintenance of ontologies with multiple inheri-
tance pathways becomes increasingly difficult with increased
size and complexity, and they are particularly difficult to
Table 2 continued
Resource URL
UniProt-GOA (Gene Ontology Annotation) http://www.ebi.ac.uk/GOA
*VeryGene http://www.verygene.com
Zebrafish Database (ZFIN) phenotype example http://zfin.org/action/phenotype/phenotype-statement?id=53698
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view for missing terms when additions are largely dictated
by the need of curation or projects to define new terms.
Missing terms can be logically assumed (i.e., if there is a
term ‘‘increased X,’’ the converse term ‘‘decreased X’’
should exist), although such terms might not be biologi-
cally relevant phenotypes. Automatic reasoners, software
tools that infer the positions of terms in a subsumption
hierarchy based on logical definitions, have been exploited
to identify missing or erroneous relationships and detect
omissions in ontologies (Mungall et al. 2011). To this end,
the tool GULO (Getting an Understanding of LOgical
definitions, http://compbio.charite.de/svn/hpo/trunk/src/tools/
gulo) (Ko¨hler et al. 2011) was applied to refine the MP.
Based on the results of reasoner analysis, MP added over
300 new child–parent relationships. This work also
uncovered discrepancies in reference ontologies used to
construct logical definitions and errors in assignment of EQ
statements. Therefore, the use of logical definitions, cou-
pled with software tool reasoners, automates some aspects
of ontology review for completeness and term placement in
the DAG, although manual verification is needed to ensure
accuracy and to place aggregate terms.
A combination of EQ statements and precomposed MP
terms can reciprocally meet the needs of automated pheno-
type annotation pipelines and biomedical researchers inter-
ested in exploring data. For example, Europhenome describes
parameters tested through the phenotyping pipeline using EQ
statements. An eye dysmorphology parameter defined by
‘‘eye’’ (MA:0000261) and ‘‘size’’ (PATO:0000117) defines
the test itself, and a phenotypic observation may then be
‘‘eye’’ and ‘‘decreased size’’ (PATO:0000587). This EQ
combination corresponds to the MP term ‘‘microphthalmia’’
(MP:0001297), or small eye, a term familiar to scientists and
clinicians and used by Europhenome in its web interface and
BioMart (Beck et al. 2009; Morgan et al. 2010).
Integration with ongoing and new systematic
phenotyping efforts
Systematic phenotyping, where many centers apply com-
mon phenotyping protocols under the same conditions
(e.g., age, sex), can provide high-quality data sets for
analysis and comparison. This interinstitution standardi-
zation of phenotype testing was experimented with and
analyzed extensively in the last decade in the European
projects of EUMORPHIA (Brown et al. 2005; Mandillo
et al. 2008) and EUMODIC (Beck et al. 2009; Morgan
et al. 2010). The role of EUMODIC was to generate phe-
notype data from the first 500 mutant mouse knockout lines
derived from the International Knockout Mouse Project
(IKMC, http://www.knockoutmouse.org) (Ringwald et al.
2011; Skarnes et al. 2011) using standardized protocols and
pipelines. The results produced by these centers are
reported through the Europhenome database (Morgan et al.
2010) and are available through a web interface or through
the IKMC BioMart (Oakley et al. 2011). In addition, data
generated by the Sanger Institute are available from their
mouse resources portal. Both of these resources perform
statistical comparisons of experimentally generated mutant
mouse phenotype data with control phenotype data to
identify significant phenodeviants. Significant results are
stored and the relevant MP term for the test result is
automatically applied to the mutant line. In addition to
automated pipelines, data also are analyzed manually at the
Sanger Institute and phenodeviant calls and MP terms are
assigned to these results. Both the Europhenome and
Sanger Institute’s Mouse Resource Portal sites allow
searching and browsing for phenodeviant data using MP
terms [see review of both of these efforts in Ayadi et al.
(2012)].
MGI is undertaking the importation of these data to
integrate them with all the resources that MGI offers.
Because these phenotype data are already associated with
MP terms, as well as official gene, allele, and strain
nomenclature and other standardized parameters, importa-
tion is automatable and thus reduces the need for further
curation. Similarly, MGI can effectively work with data
sets of increasing size, such as those expected from the
IMPC, which has a stated goal to carry out high-throughput
phenotyping for over 20,000 mutant mouse lines to deter-
mine the function of every gene in the mouse genome
(Brown and Moore 2012).
Use of phenotype ontologies and mouse phenotype
and disease annotations in research and online tools
Mouse genotypes in MGI are annotated to human disease terms
from OMIM (Amberger et al. 2011) when an author demon-
strates that the phenotype mimics the human disease state.
For example, the Fgfr2tm1Schl allele is a model of the human
disease Crouzon Syndrome (OMIM ID:123500) (Fig. 2)
Fig. 2 Example of a MGI allele detail page and associated Human
Disease and Mouse Model detail page. a The Fgfr2tm1Schl (a mutation
in the fibroblast growth factor receptor 2 gene, the first targeted
mutation from the laboratory of Joseph Schlessinger) allele record
shows nomenclature, a molecular description of the mutation, a
phenotype summary organized by systems affected in tabular format
to facilitate cross-genotype comparisons, a phenotype data by
genotype section, a human disease model section, and associated
references. b The phenotype by genotype section expands to reveal
details, including further description and citations. Two different
cohorts of mice carrying this allele have been analyzed, but only one
has been asserted to be a model of the human disease Crouzon
Syndrome (OMIM: 123500); links to both the MGI Human Disease
and Mouse Model Detail page (c) and to OMIM are provided
c
660 C. L. Smith, J. T. Eppig: Mammalian Phenotype Ontology
123
C. L. Smith, J. T. Eppig: Mammalian Phenotype Ontology 661
123
(Eswarakumar et al. 2006). Links from MGI mutant allele
details to both the OMIM record describing this condition in
humans and to MGI’s Human Disease and Mouse Model web
pages are provided. These models are searched using the
OMIM term or ID from the Quick Search Box on any MGI
page or the advanced Genes and Markers Query Form or
Phenotypes Query Form, or they may be browsed on the
Human Disease Vocabulary browser. OMIM is used as MGI’s
source of human genetic disease terms because it provides
associated detailed descriptions of human disease and clinical
synopses, associates OMIM disease records to human genes,
and is recognized and frequently used by clinicians and bio-
medical researchers as an authoritative information source.
Given the exponentially increasing amount of complex
mouse phenotype and human disease model data in MGI and
elsewhere and that these data are stored in model organism
databases using different methods, computational tools are
required that will lead to better data mining and comparison of
phenotypic data across different species. There are a number
of approaches using lexical matching or ontology mapping of
phenotype or clinical terms that map phenotypic similarity
between mouse and human genes and variants and suggest
candidate genes for human diseases [e.g., PhenomicDB,
http://www.phenomicdb.de (Groth et al. 2010); PhenoHM,
http://phenome.cchmc.org/phenoBrowser/Phenome (Sardana
et al. 2010); MouseFinder, http://www.mousemodels.org
(Chen et al. 2012); PhenomeNet, http://phenomebrowser.net
(Hoehndorf et al. 2011; Gkoutos et al. 2012; and reviewed in
Schofield et al. 2012)].
In addition to comparing data across species, MP anno-
tated phenotype data are used as a parameter by a number of
web tools that integrate published and high-throughput data
Fig. 3 Example of a comprehensive MGI data search result using the
term ‘‘ventricular septal defect.’’ Shown are samples of the results
listed from this search. All 300 genotypes in MGI that are annotated
to this term, or terms below this node in the MP, are returned. For
example, genotypes annotated to the term ‘‘inlet ventricular septal
defect,’’ a child term to ‘‘ventricular septal defect,’’ are seen in the
results list
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to facilitate gene discovery via enrichment analysis
of gene sets or to identify candidate genes for QTL.
Among the tools for enrichment analysis are MamPhea
(http://evol.nhri.org.tw/phenome/index.jsp?platform=mmus)
(Weng and Liao 2010), which enables gene enrichment
analysis of genes from multiple species based exclu-
sively on MP annotations from mouse, and ToppGene
(http://toppgene.cchmc.org/prioritization.jsp) (Chen et al.
2009), a gene enrichment tool that uses MP as one of many
parameters for sorting gene sets.
Other resources include Gene Weaver (http://www.
GeneWeaver.org) (Baker et al. 2012), which integrates sets
of biological functions (GO), their relations to mutant
phenotypes through the MP, KEGG pathways (http://www.
genome.jp/kegg/pathway.html), QTL data, and more.
VeryGene (http://www.verygene.com) (Yang et al. 2011)
links tissue-specific gene expression data to data on gene
function (GO), Reactome (http://www.reactome.org),
KEGG pathways, MP annotations, disease associations,
and targeting drugs. Among the web tools for candidate
gene identification is the AnnotQTL tool (http://annotqtl.
genouest.org) (Lecerf et al. 2011), which adds mouse MP
annotations, as well as mouse and human gene function
(GO) annotations, to genes in an identified QTL interval
region to assist in predicting candidate genes.
Using the tools described above and elsewhere, a
number of recent studies highlight the use of mouse MP
annotations in the identification or validation of candidate
gene sets in human disease and mouse studies:
• Dickerson et al. (2011) identified 1,965 human disease
genes from OMIM’s morbid map and separated them
according to whether the knockout phenotype of the
mouse ortholog was lethal (essential) or viable from
phenotype data coded to the MP in MGI. Human genes
in this set with mouse orthologs having a lethal
phenotype are over-represented among disease genes
associated with cancer and highly connected in protein–
protein interaction networks.
• Russell et al. (2012) discovered novel candidate genes for
congenital diaphragmatic hernia by expression profiling
of mouse embryonic diaphragm, then applying gene
enrichment analysis on this identified set with MGI
annotated data of muscle development and metabolism
terms in the GO and abnormal muscle and cardiovascular
phenotype terms from the MP ontology. Twenty-seven
new candidate genes were identified. One candidate gene,
pre-B-cell leukemia transcription factor one (Pbx1), when
mutated, results in a range of previously undetected
diaphragmatic defects in mice.
• Meehan et al. (2011) used MGI phenotype data associated
with MP terms and mouse model data to create a set
of similarly annotated genes/genotypes likely to have
previously uncharacterized autistic-like phenotypes. The
implicated genes considerably overlapped with a set of
over 300 human genes associated with human autism
spectrum disorder due to small, rare copy number variants
(CNVs, Pinto et al. 2010). Similarly, Gai et al. (2012)
identified 12 MP ontology term annotations that are
significantly enriched in genes overlapping inherited rare
autism CNVs and are consistent with observable pheno-
types associated with human autism spectrum disorder
behaviors.
• Shaikh et al. (2011) identified a group of genes
enriched in human developmental delay-associated
CNVs, which when disrupted in mice, result in specific
nervous system phenotypes. The most significant term
annotated to these genes was an abnormal nervous
system white matter tract phenotype, which was used to
narrow the candidate gene set for further analysis.
• Baye´s et al. (2011) identified 1,461 proteins present in
human neocortex postsynaptic density. Mutations in
199 of these genes were associated with human
neurological diseases in OMIM. Enrichment analysis
revealed 77 MP terms, including cognitive and motor
phenotypes associated with mutations in the mouse
orthologs that revealed new candidate genes. A similar
gene enrichment result was shown using the Human
Phenotype Ontology annotations derived from OMIM.
• Hageman et al. (2011) used MP annotations to kidney
phenotypes to narrow the genomic intervals and find
candidate genes for QTL affecting the urinary albumin-
to-creatinine ratio in mice.
Thus, the predictive value of mouse mutant phenotypes
in identifying new candidate genes assists researchers in
revealing the complex nature of human diseases.
Summary and future prospects
The MP ontology continues to evolve and expand to robustly
describe phenotypes. New terms and structural refinements
are incorporated as required by phenotype annotation efforts
at MGI and other databases, phenotyping centers, muta-
genesis projects, investigator research, and review by bio-
logical domain experts. MGI curates information on
published mouse mutations and electronically imports phe-
notype and disease model information from other sources.
MGI continues to adapt as new data drive database
infrastructure and as public data presentation changes. For
example, changes are already underway to accommodate
Europhenome and the Sanger Institute’s large-scale pheno-
type data derived from targeted knockout mutations, as well
as future IMPC phenotype data. Additional new sources of
mouse allele, variant, and phenotype data will arise from the
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Collaborative Cross (CC, http://csbio.unc.edu/CCstatus)
(Churchill et al 2004; Threadgill and Churchill 2012) and
the Diversity Outcross (DO, http://cgd.jax.org/datasets/
phenotype/SvensonDO.shtml) (Svenson et al. 2012), as
well as mutations induced by engineered zinc finger nuc-
leases (Osiak et al. 2011). Other mutation-generation tech-
niques, including transposon-induced mutations (cf.
Largaespada 2009; Liang et al. 2009; Takeda et al. 2007;
Wang et al. 2008), and the detection by NexGen and whole-
exome sequencing of significant numbers of previously
undetectable ENU mutations (cf. Arnold et al. 2011; Boles
et al. 2009; Guryev and Cuppen 2009; Sun et al. 2012) will
further increase the genomic mutations and phenotypic data
that require MP and nomenclature standards for integration
with existing data. The promise of integrating these many
streams of phenotype data with a robust MP ontology will
enable a growing reservoir of standardized data for data
mining, gene set enrichment studies, candidate disease
model identification, and validation of computational
predictions.
Many challenges remain in the ability to use computa-
tional tools to analyze and compare data from human
clinical and mouse phenotype resources. Human GO data
are freely available via the Universal Protein Resource GO
Annotations (UniProt-GOA, MP Ontology http://www.ebi.
ac.uk/GOA) (Dimmer et al. 2012), but genetic, disease, and
clinical data are scattered in many databases with differing
formats and accessibility, and many resources are not
maintained in a computational-friendly format (Ku¨ntzer
et al. 2010). The HP, now being adopted by resources such
as NCBI, is available for standardization of human clinical
symptoms (Robinson et al. 2008) and is mapped to OMIM
disease records. Logical definitions derived for the HP are
mapped to similar ontologies such as the MP (Mungall
et al. 2011).
The HP is only one part of the infrastructure needed for
human disease data management, however. A compre-
hensive disease ontology with descriptions and definitions
of disease terms in the context of observable clinical fea-
tures, including a mapping to other phenotype ontologies
such as HP and/or MP, is required to maximize the inter-
operability and computational access to the wide range of
human disease data. Current vocabularies for human dis-
ease have a number of drawbacks that prevent their wide
adoption as a robust source for human disease annotation.
OMIM, while an excellent source of text descriptions of
disease, lacks a hierarchical structure and is limited to
Mendelian disease. The international classification of dis-
ease (ICD, http://www.nlm.nih.gov/mesh/MBrowser.html)
is designed for physician billing codes and thus is con-
founded by many nondisease terms such as those for injury
and infection. The Systematized Nomenclature of Medi-
cine—Clinical Terms (SNOMED-CT, http://www.ihtsdo.
org/snomed-ct) must be licensed for use by country or
affiliation and is thus not a publicly available resource.
Several nascent efforts that are developing human dis-
ease ontologies/vocabularies are underway. These include
the Disease Ontology (DO, http://disease-ontology.org)
(Schriml et al. 2012), MEDIC (http://ctdbase.org/voc.
go?type=disease) (Davis et al. 2012), and Orphanet (http://
www.orpha.net/consor/cgi-bin) (Rath et al. 2012). In
addition, the Medical Subject Headings (MeSH)-disease
branch at the U.S. National Library of Medicine (Nelson
et al. 2004) is increasingly incorporating OMIM disease
terms. Ultimately, the successful growth and maturation of
one or more of these or other proposed disease ontologies
and vocabularies should lead to greater interoperability of
human genetic, disease, and clinical data among the scat-
tered resources, as well as integration with model organism
data. Adoption of semantic and syntactic standards by the
human clinical community will facilitate integration of
data from a multitude of resources and allow the ability to
compute over many data sets, as has been demonstrated for
mouse genetic and phenotype data via the MP.
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